These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1986784)

  • 1. General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate.
    Cohen SG; Chishti SB; Bell DA; Howard SI; Salih E; Cohen JB
    Biochim Biophys Acta; 1991 Jan; 1076(1):112-22. PubMed ID: 1986784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic and uncharged substrates and reversible inhibitors in hydrolysis by acetylcholinesterase (EC 3.1.1.7). The trimethyl subsite.
    Hasan FB; Elkind JL; Cohen SG; Cohen JB
    J Biol Chem; 1981 Aug; 256(15):7781-5. PubMed ID: 7263627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase: theory of noncompetitive inhibition.
    Froede HC; Wilson IB; Kaufman H
    Arch Biochem Biophys; 1986 Jun; 247(2):420-3. PubMed ID: 3717952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
    Eastman J; Wilson EJ; Cerveñansky C; Rosenberry TL
    J Biol Chem; 1995 Aug; 270(34):19694-701. PubMed ID: 7649979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of charge, volume, and surface on binding of inhibitor and substrate moieties to acetylcholinesterase.
    Cohen SG; Chishti SB; Elkind JL; Reese H; Cohen JB
    J Med Chem; 1985 Sep; 28(9):1309-13. PubMed ID: 4032433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Bromopinacolone, an active site-directed covalent inhibitor for acetylcholinesterase.
    Cohen SG; Lieberman DL; Hasan FB; Cohen JB
    J Biol Chem; 1982 Dec; 257(23):14087-92. PubMed ID: 7142196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase.
    Auletta JT; Johnson JL; Rosenberry TL
    Chem Biol Interact; 2010 Sep; 187(1-3):135-41. PubMed ID: 20493829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
    Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
    Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase.
    Lin G; Tsai YC; Liu HC; Liao WC; Chang CH
    Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into substrate traffic and inhibition in acetylcholinesterase.
    Colletier JP; Fournier D; Greenblatt HM; Stojan J; Sussman JL; Zaccai G; Silman I; Weik M
    EMBO J; 2006 Jun; 25(12):2746-56. PubMed ID: 16763558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11).
    Dodds HM; Rivory LP
    Mol Pharmacol; 1999 Dec; 56(6):1346-53. PubMed ID: 10570064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.
    Pietsch M; Christian L; Inhester T; Petzold S; Gütschow M
    FEBS J; 2009 Apr; 276(8):2292-307. PubMed ID: 19292865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorimetric Differentiation of Flavonoids Based on Effective Reactivation of Acetylcholinesterase Induced by Different Affnities between Flavonoids and Metal Ions.
    Li S; Liu X; Liu Q; Chen Z
    Anal Chem; 2020 Feb; 92(4):3361-3365. PubMed ID: 31983197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple binding of D-tubocurarine to acetylcholinesterase.
    Zorko M; Pavlic MR
    Biochem Pharmacol; 1986 Jul; 35(14):2287-96. PubMed ID: 3729986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
    Berman HA; Leonard K
    Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesterase.
    Stojan J; Marcel V; Estrada-Mondaca S; Klaebe A; Masson P; Fournier D
    FEBS Lett; 1998 Nov; 440(1-2):85-8. PubMed ID: 9862431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformers of acetylcholinesterase: a mechanism of allosteric control.
    Taylor JL; Mayer RT; Himel CM
    Mol Pharmacol; 1994 Jan; 45(1):74-83. PubMed ID: 8302283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.